WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) announced that Shai N. Gozani, M.D., Ph.D., President and CEO, will participate in a panel titled “Roadmap to FDA Approval” on Tuesday, January 5 at the 2016 CES Event in Las Vegas. The panel moderator is Alfred Poor, Editor of Health Tech Insider. Dr. Gozani will be joined by other industry thought leaders including Dr. Nick van Terheyden, M.D., Chief Medical Officer at Dell, Bakul Patel, Associate Center Director for Digital Health at FDA, and Beth Bierman, Partner at Morgan Lewis & Bockius. The panel will address the opportunities and challenges of regulated wearable medical devices and apps. CES is the largest consumer technology event and has served as the launch pad for innovators and breakthrough technologies for almost 50 years. CES attracts global business leaders and pioneering thinkers to a forum where the industry’s most relevant issues are addressed.
